Keywords: همزمان شیمی درمانی; Carboplatin; Cervical cancer; Concurrent chemoradiotherapy; Meta-analysis;
مقالات ISI همزمان شیمی درمانی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: همزمان شیمی درمانی; SCCHN; squamous cell carcinoma of the head and neck; SEER; Surveillance, Epidemiology, and End Results; HPV; human papillomavirus; LA; locoregionally advanced; Gy; gray; RTOG; Intergroup Radiation Therapy Oncology Group; GORTEC; Groupe d'Oncologie Radioth
Keywords: همزمان شیمی درمانی; Nasopharyngeal carcinoma; Serum bilirubin; Prognostic value; Concurrent chemoradiotherapy; Survival; Indirect bilirubin; Direct bilirubin;
Keywords: همزمان شیمی درمانی; cCRT; Concurrent chemoradiotherapy; Dose-escalation; Stage 3; NSCLC; Heterogeneity;
Keywords: همزمان شیمی درمانی; Malignant glioma; Sustained-release carboplatin; Thermogelling hydrogel; Intratumoral injection; Simplified drug delivery; Concurrent chemoradiotherapy;
Keywords: همزمان شیمی درمانی; RT; radiotherapy; CT; chemotherapy; IMRT; intensity-modulated radiotherapy; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; CCRT; concurrent chemoradiotherapy; AJCC; American Joint Committee on Cancer; HR; hazard
Keywords: همزمان شیمی درمانی; Head and neck cancer; Breakthrough cancer pain; Mucositis; Dysphagia; Concurrent chemoradiotherapy; Treatment intensity; Quality of life;
Keywords: همزمان شیمی درمانی; Esthesioneuroblastoma; Olfactory neuroblastoma; Prognostic factor; Surgical procedure; Concurrent chemoradiotherapy; Radiotherapy;
Keywords: همزمان شیمی درمانی; AC; adenocarcinoma; ARCON; accelerated radiotherapy with carbogen breathing and nicotinamide; CA IX; carbonic anhydrase; CCRT; concurrent chemoradiotherapy; CR; complete response; Cu-ATSM,; copper-62 labeled diacetyl-bis (N4-methylthiosemicarbazone); DFS;
Keywords: همزمان شیمی درمانی; Cardiac radiotherapy; Concurrent chemoradiotherapy; Dose-escalated radiation; Locally advanced NSCLC; Stage III;
Keywords: همزمان شیمی درمانی; Esophageal squamous cell carcinoma; Concurrent chemoradiotherapy; Radiotherapy dose;
Keywords: همزمان شیمی درمانی; Locally-advanced pancreatic carcinoma; Pretreatment weight loss; Survival; Concurrent chemoradiotherapy; Percentage weight loss; Weight loss degree;
Keywords: همزمان شیمی درمانی; Acute esophagitis; Non small cell lung cancer; IMRT; Concurrent chemoradiotherapy
Keywords: همزمان شیمی درمانی; Concurrent chemoradiotherapy; pulp vitality; radiotherapy
Keywords: همزمان شیمی درمانی; Induction chemotherapy; Concurrent chemoradiotherapy; Nasopharyngeal carcinoma; Time-to-event; Meta-analysis
Keywords: همزمان شیمی درمانی; Concurrent chemoradiotherapy; Non-small cell lung cancer; Postoperative recurrence; Postrecurrence survival; Prognostic factors
Keywords: همزمان شیمی درمانی; Cervical cancer; Complications; Concurrent chemoradiotherapy; Surgery
Keywords: همزمان شیمی درمانی; Concurrent chemoradiotherapy; Neutrophil-to-lymphocyte ratio; Oesophageal cancer; Prognosis;
Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma
Keywords: همزمان شیمی درمانی; Nasopharyngeal carcinoma; IMRT; Concurrent chemoradiotherapy; Nimotuzumab; Cetuximab; Survival outcome; Adverse events;
A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma
Keywords: همزمان شیمی درمانی; Nasopharyngeal carcinoma; Induction chemotherapy; Interaction effect; Prognostic index; Benefit prediction model; Distant metastasis-free survival; aHR; adjusted hazard ratio; AJCC/UICC; American Joint Committee on Cancer/International Union against Cance
Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis
Keywords: همزمان شیمی درمانی; Nasopharyngeal carcinoma; Sequential chemoradiotherapy; Concurrent chemoradiotherapy; Intensity-modulated radiotherapy; Induction chemotherapy; Survival;
Image-guided adaptive brachytherapy in primary vaginal cancers: AÂ monocentric experience
Keywords: همزمان شیمی درمانی; Vaginal cancer; Concurrent chemoradiotherapy; Image-guided adaptive brachytherapy; Dose-volume histograms;
Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer
Keywords: همزمان شیمی درمانی; ASA; American Society of Anesthesiologists physical status classification system; cGy; centigray; Ch; chemotherapy only; CI; confidence interval; CRT; concurrent chemoradiotherapy; CR; complete response; CT; computed tomography; DFI; disease free interval
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials
Keywords: همزمان شیمی درمانی; N3; Head and neck cancer; Accelerated radiotherapy; Concurrent chemoradiotherapy; Oropharyngeal cancer; Distant metastasis;
Phase II trialA phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer
Keywords: همزمان شیمی درمانی; Head and neck cancer; Concurrent chemoradiotherapy; Efficacy; Toxicity; Quality of life;
A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas
Keywords: همزمان شیمی درمانی; Soft tissue sarcoma; Adjuvant treatment; Concurrent chemoradiotherapy; Local control; Toxicity;
Original ResearchQuality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (
Keywords: همزمان شیمی درمانی; Randomised clinical trial; Phase III clinical trial; Head and neck neoplasms; Intensity-modulated radiation therapy; Cisplatin; Concurrent chemoradiotherapy; Quality of life; Swallowing; Patient-reported outcomes;
Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium
Keywords: همزمان شیمی درمانی; Concurrent chemoradiotherapy; non-small cell lung cancer; observational study; sequential chemoradiotherapy;
Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy
Keywords: همزمان شیمی درمانی; Nasopharyngeal carcinoma; Induction chemotherapy; Concurrent chemoradiotherapy; Nomograms; Survival; TNM staging system;
Clinical TrialNeoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
Keywords: همزمان شیمی درمانی; Locoregionally advanced nasopharyngeal carcinoma; Neoadjuvant chemotherapy; Concurrent chemoradiotherapy; Randomised controlled trial;
Central pontine myelinolysis (CPM) and extrapontine myelinolysis (EPM) following concurrent chemoradiotherapy for nasopharyngeal carcinoma
Keywords: همزمان شیمی درمانی; Central pontine myelinosis; Extrapontine myelinosis; Nasopharyngeal carcinoma; Hyponatremia; Concurrent chemoradiotherapy
Prognostic value of diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography after concurrent chemoradiotherapy in uterine cervical cancer
Keywords: همزمان شیمی درمانی; Diffusion-weighted imaging; PET/CT; Cervical cancer; Concurrent chemoradiotherapy; Disease progression;
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab
Keywords: همزمان شیمی درمانی; Concurrent chemoradiotherapy; Non-small cell lung cancer; Hypofractionation; RTOG0617
Surgical resection or additional radiotherapy after superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique and concurrent chemoradiotherapy for T3 or T4 oral squamous cell carcinoma
Keywords: همزمان شیمی درمانی; Chemoradiotherapy; Concurrent chemoradiotherapy; Oral squamous cell carcinoma; Intra-arterial; Quality of life
Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma
Keywords: همزمان شیمی درمانی; Nasopharyngeal carcinoma; Induction chemotherapy; Concurrent chemoradiotherapy;
Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer
Keywords: همزمان شیمی درمانی; Cetuximab; Induction chemotherapy; Concurrent chemoradiotherapy; Locally advanced; Non-small cell lung cancer;
Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer
Keywords: همزمان شیمی درمانی; Cervical carcinoma; Concurrent chemoradiotherapy; DCE-MRI; Semiquantitative analysis; Treatment outcome;
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non–Small-Cell Lung Cancer: SWOG S0533
Keywords: همزمان شیمی درمانی; Bevacizumab; Cisplatin/etoposide; Concurrent chemoradiotherapy; Locally advanced NSCLC; Non–small-cell lung cancer
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type
Keywords: همزمان شیمی درمانی; Extranodal NK/T-cell lymphoma nasal type; Concurrent chemoradiotherapy; Radiosensitive chemotherapy; Multidrug resistance;
Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Treatment outcomes of a prospective, multicentric clinical study
Keywords: همزمان شیمی درمانی; Nasopharyngeal carcinoma; Intensity-modulated radiotherapy; Concurrent chemoradiotherapy; Prospective study; Clinical outcome;
Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Efficacy and safety outcomes of a randomized, multi-center phase II study investigating
Keywords: همزمان شیمی درمانی; NSCLC; Concurrent chemoradiotherapy; Cetuximab;
A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin-Vinorelbine-Cetuximab in Patients With Stage III Non-Small-Cell Lung Cancer
Keywords: همزمان شیمی درمانی; NSCLC; Concurrent chemoradiotherapy; Cetuximab; Phase I;
Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging
Keywords: همزمان شیمی درمانی; Cervical cancer; Concurrent chemoradiotherapy; Diffusion-weighted MRI; Dynamic contrast-enhanced MRI; Biomarker
How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?
Keywords: همزمان شیمی درمانی; Non-small cell lung cancer; Concurrent chemoradiotherapy; Radiotherapy; Inoperable; Elderly; Dose-escalation;
The Efficacy of Induction Chemotherapy with Docetaxel, Cisplatin and 5-fluorouracil Combined with Cisplatin Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Matched Pair Analysis
Keywords: همزمان شیمی درمانی; Cisplatin; concurrent chemoradiotherapy; docetaxel; head and neck squamous cell carcinoma; induction chemotherapy;
Outcomes of aggressive concurrent radiochemotherapy in highly selected septuagenarians with stage IIIB non-small cell lung carcinoma: Retrospective analysis of 89 patients
Keywords: همزمان شیمی درمانی; Elderly; Non-small cell lung cancer; Stage IIIB; Concurrent chemoradiotherapy; Survival outcome; Treatment tolerability
Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin Followed by Pemetrexed Consolidation Therapy in Japanese Patients With Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer
Keywords: همزمان شیمی درمانی; Cisplatin; Concurrent chemoradiotherapy; Nonsquamous NSCLC; Pemetrexed
Tumor Cavitation in Patients With Stage III Non–Small-Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy: Incidence and Outcomes
Keywords: همزمان شیمی درمانی; NSCLC; Stage III; Concurrent chemoradiotherapy; Tumor cavitation; Toxicity
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Keywords: همزمان شیمی درمانی; Nasopharyngeal carcinoma; Head and neck cancer; Concurrent chemoradiotherapy; Cisplatin; Dose intensity; Prognostic factor
Impact of omission of elective nodal irradiation on treatment outcomes in locally advanced pancreatic adenocarcinoma patients treated with definitive concurrent chemoradiotherapy
Keywords: همزمان شیمی درمانی; Locally advanced pancreatic carcinoma; Concurrent chemoradiotherapy; Limited-field irradiation; Survival outcomes;